Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
65,606,830
-
Total 13F shares
-
26,183,049
-
Share change
-
-1,158,861
-
Total reported value
-
$30,634,167
-
Price per share
-
$1.17
-
Number of holders
-
19
-
Value change
-
-$1,443,320
-
Number of buys
-
6
-
Number of sells
-
5
Institutional Holders of IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT) as of Q2 2024
As of 30 Jun 2024 IO Biotech, Inc. - Common stock, par value $0.001 per share (IOBT) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,183,049 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, Novo Holdings A/S, Samsara BioCapital, LLC, PFM Health Sciences, LP, MARSHALL WACE, LLP, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, ARMISTICE CAPITAL, LLC, Pivotal bioVenture Partners Investment Advisor LLC, and Logos Global Management LP.
This table shows 19 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.